Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study | Scientific Reports – Nature.com

Darroudi, S. et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J. Clin. Lab. Anal. 32(8), e22579 (2018).

PubMed PubMed Central Article CAS Google Scholar

Huang, C. et al. Prevalence and related factors of dyslipidemia among urban adults aged 35 to 79 years in Southwestern China. Sci. Rep. 11(1), 18 (2021).

Article CAS Google Scholar

Toori, M. A. et al. Prevalence of hypercholesterolemia, high LDL, and low HDL in Iran: A systematic review and meta-analysis. Iran. J. Med. Sci. 43(5), 449 (2018).

Google Scholar

Modelli, M. E., Cherulli, . S., Gandolfi, L. & Pratesi, R. Atherosclerosis in young Brazilians suffering violent deaths: a pathological study. BMC. Res. Notes 4(1), 531 (2011).

PubMed PubMed Central Article Google Scholar

Lee, J. S. et al. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care 40(4), 529537 (2017).

PubMed PubMed Central Article Google Scholar

Liu, X. et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 17(1), 119 (2018).

PubMed PubMed Central Article Google Scholar

Najafipour, H. & Beik, A. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Front. Physiol. 7, 436 (2016).

PubMed PubMed Central Article Google Scholar

Yousefzadeh, G., Shokoohi, M., Najafipour, H., Eslami, M. & Salehi, F. Association between opium use and metabolic syndrome among an urban population in Southern Iran: results of the Kerman Coronary Artery Disease Risk Factor Study (KERCADRS). ARYA Atherosclerosis 11(1), 14 (2015).

PubMed PubMed Central Google Scholar

Ziaaddini, H., Ziaaddini, T. & Nakhaee, N. Pattern and trend of substance abuse in eastern rural Iran: A household survey in a rural community. J. Addict. 2013 (2013).

Farjam, M. et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study. BMC Public Health 16(1), 18 (2016).

Article Google Scholar

Mami, S. et al. Effect of opium addiction on some serum parameters in rabbit. Glob Vet. 7, 310314 (2011).

CAS Google Scholar

Fatemi, S. S., Hasanzadeh, M., Arghami, A. & Sargolzaee, M. R. Lipid profile comparison between opium addicts and non-addicts. J. Tehran Univ. Heart Center. 3(3), 169172 (2008).

CAS Google Scholar

Nakhaee, S. et al. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Substance Abuse Treat. Prevent. Policy 15(1), 113 (2020).

Article Google Scholar

Niaki, M. R. K., Hamid, M., Farshidi, F., Mohammadpour, M. & Omran, M. T. S. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J. Intern. Med. 4(1), 585 (2013).

Google Scholar

Khalili, P. et al. Effect of opium consumption on cardiovascular diseasesA cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc. Disord. 21(1), 111 (2021).

Article CAS Google Scholar

Marmor, M., Penn, A., Widmer, K., Levin, R. I. & Maslansky, R. Coronary artery disease and opioid use. Am. J. Cardiol. 93(10), 12951297 (2004).

PubMed Article Google Scholar

Nikparvar, M. et al. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci. Rep. 11(1), 111 (2021).

Article CAS Google Scholar

Abujbara, M., Batieha, A., Khader, Y., Jaddou, H., El-Khateeb, M. & Ajlouni, K. The Prevalence of dyslipidemia among Jordanians. J. Lipids. 2018 (2018).

Rinknien, E. et al. The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania. Clin. Lipidol. 10(3), 219225 (2015).

Article CAS Google Scholar

Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187(4), 647655 (2018).

PubMed Article Google Scholar

Hakimi, H., Ahmadi, J., Vakilian, A., Jamalizadeh, A., Kamyab, Z., Mehran, M. et al. The profile of Rafsanjan Cohort Study. Eur. J. Epidemiol. 110 (2020).

Kazemi, M. et al. Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results. Sci. Rep. 11(1), 19 (2021).

Article CAS Google Scholar

Rezaei, M., Fakhri, N., Pasdar, Y., Moradinazar, M. & Najafi, F. Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study. Lipids Health Dis. 19(1), 18 (2020).

Article CAS Google Scholar

Ebrahimi, H., Emamian, M. H., Hashemi, H. & Fotouhi, A. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes Metab. Syndr. 10(3), 149156 (2016).

PubMed Article Google Scholar

Petrella, R. J., Merikle, E. & Jones, J. Prevalence and treatment of dyslipidemia in Canadian primary care: A retrospective cohort analysis. Clin. Ther. 29(4), 742750 (2007).

PubMed Article Google Scholar

Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran. BMJ. 2012;344.

Meysamie, A., Sedaghat, M., Mahmoodi, M., Ghodsi, S. & Eftekhar, B. Opium use in a rural area of the Islamic Republic of Iran. EMHJ-Eastern Mediterr. Health J. 15(2), 425431 (2009).

CAS Article Google Scholar

Rezaei, Z., Zarei, F., Firoozi, E. & Ahmadi, D. Pattern of illegal drug use in women referred to substance abuse control Clinic in Fasa, Iran (20092011). J. Fasa Univ. Med. Sci. 3(4), 305311 (2014).

Google Scholar

Gozashti, M. H., Yazdi, F., Salajegheh, P., Dehesh, M. M. & Divsalar, K. Fasting blood glucose and insulin level in opium addict versus non-addict individuals. Addict. Health. 7(12), 54 (2015).

PubMed PubMed Central Google Scholar

Afarinesh, M. R. et al. Changes in serum biochemical factors associated with opium addiction after addiction desertion. Addict. Health. 6(34), 138 (2014).

PubMed PubMed Central Google Scholar

Masoomi, M., Azdaki, N. & Shahouzehi, B. Elevated plasma homocysteine concentration in opium-addicted individuals. Addict. Health. 7(34), 149 (2015).

PubMed PubMed Central Google Scholar

Sanli, D. B. et al. Effect of different psychoactive substances on serum biochemical parameters. Int. J. High Risk Behav. Addict. 4(2), e22702 (2015).

PubMed PubMed Central Article Google Scholar

Asgary, S., Sarrafzadegan, N., Naderi, G.-A. & Rozbehani, R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?. Lipids Health Dis. 7(1), 15 (2008).

Article CAS Google Scholar

Aghadavoudi, O., Eizadi-Mood, N. & Najarzadegan, M. R. Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery. Adv. Biomed. Res. 4, 12 (2015).

PubMed PubMed Central Article Google Scholar

Salman, T. M. et al. Oxidative stress and lipotoxicity of bhang and opium addiction. Effects on adrenal gland secretions. Dyn. Biochem. Proc. Biotechnol. Mol. Biol. 4, 5054 (2010).

Google Scholar

Hosseini, S. K. et al. Opium consumption and coronary atherosclerosis in diabetic patients: A propensity score-matched study. Planta Med. 77, 18701875 (2011).

CAS PubMed Article Google Scholar

Mohammadi, A. et al. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp. Toxicol. Pathol. 61(2), 145149 (2009).

CAS PubMed Article Google Scholar

Najafipour, H., Joukar, S., Malekpour-Afshar, R., Mirzaeipour, F. & Nasri, H. R. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J. Ethnopharmacol. 127(2), 257263 (2010).

CAS PubMed Article Google Scholar

Ahmadi, J., Babaee-Beigi, M., Alishahi, M., Maany, I. & Hidari, T. Twelve-month maintenance treatment of opium-dependent patients. J. Subst. Abuse Treat. 26(1), 6164 (2004).

Article Google Scholar

Kouros, D., Tahereh, H., Mohammadreza, A. & Minoo, M. Z. Opium and heroin alter biochemical parameters of humans serum. Am. J. Drug Alcohol Abuse 36(3), 135139 (2010).

PubMed Article Google Scholar

Bryant, H. U., Kuta, C. C., Story, J. A. & Yim, G. K. Stress-and morphine-induced elevations of plasma and tissue cholesterol in mice: Reversal by naltrexone. Biochem. Pharmacol. 37(19), 37773780 (1988).

CAS PubMed Article Google Scholar

Zhang, Y. T., Zheng, Q. S., Pan, J. & Zheng, R. L. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin. Pharmacol. Toxicol. 95(2), 5358 (2004).

CAS PubMed Article Google Scholar

Ili, G., Karadi, R., Kosti-Banovi, L. & Stojanovi, J. Chronic intravenous heroin abuse: impact on the liver. Med Biol. 12, 150153 (2005).

Google Scholar

Ghadir, M. R., Riahin, A. A., Havaspour, A., Nooranipour, M. & Habibinejad, A. A. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat. Mon. 10(4), 285 (2010).

PubMed PubMed Central Google Scholar

Maccari, S., Bassi, C., Zanoni, P. & Plancher, A. C. Plasma cholesterol and triglycerides in heroin addicts. Drug Alcohol Depend. 29(2), 183187 (1991).

CAS PubMed Article Google Scholar

Moshtaghi-Kashanian, G. R., Esmaeeli, F. & Dabiri, S. Enhanced prolactin levels in opium smokers. Addict. Biol. 10(4), 345349 (2005).

CAS PubMed Article Google Scholar

Hamrah, M. S. et al. Impact of opium use on the conventional coronary artery risk factors among outpatients in Afghanistan: A case-control study In Andkhoy City. Pak. J. Med. Health Sci. 15(1), 461467 (2021).

Google Scholar

Sheikh, M. et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob. Health 8(5), e649e660 (2020).

PubMed PubMed Central Article Google Scholar

Ziaee, M. et al. Cardiovascular complications of chronic opium consumption: A narrative review article. Iran. J. Public Health 48(12), 2154 (2019).

PubMed PubMed Central Google Scholar

Gryczynski, J., Schwartz, R. P., Mitchell, S. G., OGrady, K. E. & Ondersma, S. J. Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. Drug Alcohol Depend. 141, 4450 (2014).

CAS PubMed PubMed Central Article Google Scholar

Harrison LD, Hughes A. The validity of self-reported drug use: Improving the accuracy of survey estimates: US Department of Health and Human Services, National Institutes of Health; 1997.

Yacoubian, G. S., VanderWall, K. L., Johnson, R. J., Urbach, B. J. & Peters, R. J. Comparing the validity of self-reported recent drug use between adult and juvenile arrestees. J. Psychoact. Drugs 35(2), 279284 (2003).

Article Google Scholar

Tourangeau, R. & Yan, T. Sensitive questions in surveys. Psychol. Bull. 133(5), 859 (2007).

Read more:
Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study | Scientific Reports - Nature.com